AppPriceData観測済みデータ
AppPriceData
Agency for Clinical Innovation
Thinksulin was developed by ACI in consultation with the NSW Diabetes Taskforce and its In-hospital Management of Diabetes Mellitus Working Group and informed by: an evidence check of best practice care components of inpatient insulin management brokered by the Sax Institute for the Agency for Clinical Innovation (2024); clinician and consumer consultations; and clinical expertise.
最新の観測ダウンロード価格は 無料 です。現在の決済価格は公式 App Store リンクで確認してください。
Apple の公開 App Store ページで現在確認できる項目です。App Store Connect の完全な商品一覧とは限りません。
情報源：Apple 公開 App Store ページ · 公開項目のみ
Thinksulin was developed by ACI in consultation with the NSW Diabetes Taskforce and its In-hospital Management of Diabetes Mellitus Working Group and informed by: an evidence check of best practice care components of inpatient insulin management brokered by the Sax Institute for the Agency for Clinical Innovation (2024); clinician and consumer consultations; and clinical expertise.
Thinksulin aims to enhance the capacity and/or capability of junior medical officers and nursing staff responsible for prescribing and administering of insulin to patients in hospital with diabetes, although it can be used by any clinician responsible for the care of people in hospital with diabetes.
Thinksulin is a point of care app that provides information and decision support on blood glucose level targets, hypoglycaemia management, blood glucose monitoring, basal-bolus calculations, and charting and reviewing doses.
最新の App Store 観測データに基づく回答です。
最新の観測ダウンロード価格は Free です。現在の決済価格は公式 App Store リンクで確認してください。
Apple の公開ページでは現在、このストアで 0 件の購入項目が表示されています。公開一覧は完全ではない場合があります。
